Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kaiser

Showing results (11-20 of 640) with videos related to

Pageof 64
Sort By:
Ophthalmology. Retina|September 28, 2021
OCT Alone to Diagnose and Manage Polypoidal Choroidal Vasculopathy: Are We There?Peter K Kaiser
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 1, 1972
Colour vision in the legally blindP K Kaiser
Current Medical Research and Opinion|June 23, 2005
Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effectPeter K Kaiser
Ophthalmology|May 7, 2013
Emerging therapies for neovascular age-related macular degeneration: drugs in the pipelinePeter K Kaiser
Vision Research|January 1, 1988
Sensation luminance: a new name to distinguish CIE luminance from luminance dependent on an individual's spectral sensitivityP K Kaiser
Current Medical Research and Opinion|March 16, 2007
Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degenerationP K Kaiser
American Journal of Ophthalmology|October 3, 2006
Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseasesPeter K Kaiser
Ophthalmology|December 1, 1995
A comparison of pressure patching versus no patching for corneal abrasions due to trauma or foreign body removal. Corneal Abrasion Patching Study GroupP K Kaiser
Current Medical Research and Opinion|June 18, 2009
Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trialPeter K Kaiser,
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 16, 2006
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8Peter K Kaiser,
Pageof 64

Showing results (11-20 of 640) with videos related to

Sort By:
Pageof 64
Ophthalmology. Retina|September 28, 2021
OCT Alone to Diagnose and Manage Polypoidal Choroidal Vasculopathy: Are We There?Peter K Kaiser
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 1, 1972
Colour vision in the legally blindP K Kaiser
Current Medical Research and Opinion|June 23, 2005
Verteporfin therapy in combination with triamcinolone: published studies investigating a potential synergistic effectPeter K Kaiser
Ophthalmology|May 7, 2013
Emerging therapies for neovascular age-related macular degeneration: drugs in the pipelinePeter K Kaiser
Vision Research|January 1, 1988
Sensation luminance: a new name to distinguish CIE luminance from luminance dependent on an individual's spectral sensitivityP K Kaiser
Current Medical Research and Opinion|March 16, 2007
Verteporfin photodynamic therapy and anti-angiogenic drugs: potential for combination therapy in exudative age-related macular degenerationP K Kaiser
American Journal of Ophthalmology|October 3, 2006
Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseasesPeter K Kaiser
Ophthalmology|December 1, 1995
A comparison of pressure patching versus no patching for corneal abrasions due to trauma or foreign body removal. Corneal Abrasion Patching Study GroupP K Kaiser
Current Medical Research and Opinion|June 18, 2009
Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trialPeter K Kaiser,
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 16, 2006
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8Peter K Kaiser,
Pageof 64